H-1B Wage Lookup

Data through FY2026 Q3 (Jun 30, 2026)

Addition Therapeutics, Inc.

Company profile for Addition Therapeutics, Inc. covers 4 filings across the reporting window. FY2026 certified median offer: $116,800.

FY2026 certified median
$116,800
Total filings
4
FY2026 25th–75th percentile
$107,950–$128,507
Top job title
Scientist II Therapeutic Retro Transposase Engineering
Certified offers by fiscal year
Fiscal yearFilingsMedian25th percentile75th percentile
FY20251$94,000$94,000$94,000
FY2026 (Q1–Q3)3$116,800$107,950$128,507

FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.

Median offer by fiscal year

Certified median offer, Addition Therapeutics, Inc.FY2025 $94,000; FY2026 (Q1–Q3) $116,800$0$40,000$80,000$120,000FY2025$94,000FY2026 (Q1–Q3)$116,800Certified median offer, Addition Therapeutics, Inc.FY2025 $94,000; FY2026 (Q1–Q3) $116,800$0$40k$80k$120kFY2025$94,000FY2026*$116,800
Certified H-1B LCAs, $15k–$2M, DOL OFLC

Top titles

  1. Scientist II Therapeutic Retro Transposase Engineering2 filings
  2. Senior Research Associate II1 filings
  3. Senior Research Associate, RNA Services1 filings

Top cities

  1. South San Francisco4 filings

Employer and title details